We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-3.83%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$723M
AUM Growth
-$101M
Cap. Flow
-$40.9M
Cap. Flow %
-5.66%
Top 10 Hldgs %
78.48%
Holding
32
New
2
Increased
9
Reduced
7
Closed
4

Top Buys

Rank Stock Value
1
CMRX
Chimerix, Inc.
CMRX
+$14.6M
2
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$7.84M
3
BIOL
Biolase, Inc.
BIOL
+$5.15M
4
AMRN
Amarin Corp
AMRN
+$2.83M
5
YTEN
Yield10 Bioscience, Inc. Common Stock
YTEN
+$2.68M

Top Sells

Rank Stock Value
1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$24.8M
2
THC icon
Tenet Healthcare
THC
+$12M
3
GTIV
GENTIVA HEALTH SERVICES INC
GTIV
+$9.07M
4
THOR
THORATEC CORPORATION
THOR
+$6.94M
5
BLUE
bluebird bio
BLUE
+$6.9M

Sector Composition

Rank Sector Weight
1 Healthcare 79.28%
2 Consumer Staples 0.66%
3 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$117M 16.12%
542,589
+3,183
+0.6% +$619K
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$78.3M 10.84%
2,915,633
– –
THC icon
3
Tenet Healthcare
THC
$22.6B
$77.5M 10.72%
1,304,217
-214,659
-14% -$12M
ACOR
4
DELISTED
Acorda Therapeutics
ACOR
$62.7M 8.68%
15,426
-669
-4% -$2.51M
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
$49.3M 6.82%
3,754,343
+30,936
+0.8% +$417K
OPK icon
6
Opko Health
OPK
$1.25B
$48.9M 6.77%
5,748,764
+93,026
+2% +$818K
MZOR
7
DELISTED
Mazor Robotics Ltd.
MZOR
$37.2M 5.14%
3,154,281
– –
TTHI
8
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$33.5M 4.63%
4,851,321
– –
THOR
9
DELISTED
THORATEC CORPORATION
THOR
$32.7M 4.52%
1,222,000
-244,304
-17% -$6.94M
HNSN
10
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$30.7M 4.25%
2,602,798
+648,144
+33% +$7.84M
ARAY icon
11
Accuray
ARAY
$29M
$26.5M 3.66%
3,646,909
+30,616
+0.8% +$248K
BIOL
12
DELISTED
Biolase, Inc.
BIOL
$20.9M 2.9%
673
+182
+37% +$5.15M
CMRX
13
DELISTED
Chimerix, Inc.
CMRX
$16.6M 2.29%
+600,000
New +$14.6M
PACB icon
14
Pacific Biosciences
PACB
$432M
$15.8M 2.19%
3,225,518
+223,010
+7% +$1.17M
TSRO
15
DELISTED
TESARO, Inc.
TSRO
$15M 2.07%
556,379
-77,373
-12% -$2.27M
VRML
16
DELISTED
Vermillion, Inc.
VRML
$12.8M 1.77%
7,139,960
– –
WBMD
17
DELISTED
WebMD Health Corp.
WBMD
$10.5M 1.46%
252,098
-48,043
-16% -$2.32M
RPRX
18
DELISTED
Repros Therapeutics Inc.
RPRX
$10M 1.39%
1,014,164
-252,962
-20% -$3.75M
PGEN icon
19
Precigen
PGEN
$1.97B
$6.85M 0.95%
385,574
– –
AMRN
20
Amarin Corp
AMRN
$293M
$5.92M 0.82%
271,750
+86,750
+47% +$2.83M
YTEN
21
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$4.76M 0.66%
91
+62
+214% +$2.68M
AGEN
22
Agenus
AGEN
$275M
$3.61M 0.5%
59,160
– –
DSCI
23
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$2.72M 0.38%
326,844
-165,952
-34% -$1.54M
BIIB icon
24
Biogen
BIIB
$30.4B
$2.56M 0.35%
7,723
– –
LTS
25
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$474K 0.07%
111,789
– –
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2014 Portfolio in Review

As of Q3 2014, Oracle Investment Management held 32 positions worth $723M, down 12% from $824M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Oracle Investment Management withdrew a net $40.9M in Q3 2014, closing 4 positions and reducing 7 holdings. Its most notable exit was Ironwood Pharmaceuticals, an estimated $24.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 77% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Oracle Investment Management opened a new position in Chimerix, Inc. worth $16.6M.

  • Oracle Investment Management's largest Q3 2014 buy was Chimerix, Inc.: 600,000 shares worth $16.6M.
  • Oracle Investment Management added most to HANSEN MEDICAL, INC. COM NEW in Q3 2014, an estimated $7.84M increase.
  • Oracle Investment Management's biggest Q3 2014 reduction was Tenet Healthcare, cutting an estimated $12M.
  • Oracle Investment Management fully exited Ironwood Pharmaceuticals in Q3 2014, selling an estimated $24.8M.
  • Oracle Investment Management's ten largest holdings make up 78% of its $723M portfolio in Q3 2014.
  • Oracle Investment Management opened 2 new positions and closed 4 in Q3 2014.
  • Oracle Investment Management's portfolio value fell 12% quarter-over-quarter to $723M.

Based on Oracle Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.